Lisa Dietz

This inventor holds 18 USPTO granted patents and 22 published patent applications and 10 EPO patents, primarily in Antibody Drug Conjugates. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Aktiengesellschaft. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lisa Dietz. Retrieved from https://idiyas.com/inventor/lisa-dietz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 22)

% Patents Active = 61.1

EPO Patents = 10 (Patent Applications = 31)

Average Co-Inventor Count = 10.5

ph-index = 3

Forward Citations = 24(Granted Patents)

Company Filing History:

15 out of 387

Bayer Pharma Aktiengesellschaft

patents

9 out of 12,270

Bayer Aktiengesellschaft

patents

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Antibody Drug Conjugates

Prodrugs

Cardiopulmonary Disorders

Cytotoxic Agents

Kinesin Spindle Protein

Enzymatically Cleavable

Pyrazolo Compounds

Imidazo Compounds

Cancer Therapies

Aminosubstituted Compounds

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12595247 - Substituted pyrazolo piperidine carboxylic acids (2026-04-07),

2. 12540134 - Inhibitors of adrenoreceptor ADRAC2 (2026-02-03),

3. 12195448 - Substituted pyrazolo piperidine carboxylic acids (2025-01-14),

4. 12138256 - Treatment of cardiopulmonary disorders (2024-11-12),

5. 12059472 - Prodrugs of cytotoxic active agents having enzymatically cleavable groups (2024-08-13),

6. 11685714 - Prodrugs of cytotoxic active agents having enzymatically cleavable groups (2023-06-27),

7. 11660351 - Antibody drug conjugates (ADCs) having enzymatically cleavable groups (2023-05-30),

8. 11478554 - Antibody drug conjugates (ADCS) having enzymatically cleavable groups (2022-10-25),

9. 11433140 - Specific antibody drug conjugates (ADCs) having KSP inhibitors (2022-09-06),

10. 11149018 - Substituted N-arylethyl-2-aminoquinoline-4-carboxamides and use thereof (2021-10-19),

11. 11136296 - Substituted-arylethyl-2-arylquinoline-4-carboxamides and use thereof (2021-10-05),

12. 11071788 - Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies (2021-07-27),

13. 10292970 - Heteroaryl-substituted imidazo[1,2-A]pyridines and their use (2019-05-21),

14. 10214526 - Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof (2019-02-26),

15. 10174021 - Substituted pyrazolo[1,5-A]pyridines and their use (2019-01-08),

As you requested an article about inventor Lisa Dietz, who is a dedicated innovator pushing the boundaries of technology for a sustainable future, here is the content:

Title: Lisa Dietz - Pioneering Sustainable Solutions through Innovation

Introduction:

In the realm of innovative thinkers, Lisa Dietz stands out as a visionary inventor in the modern era, dedicated to creating a more sustainable future through her groundbreaking inventions.

Latest Patents:

With an impressive portfolio of 14 patents, Lisa's latest patents include "Prodrugs of cytotoxic active agents having enzymatically cleavable groups." This invention focuses on novel prodrugs that are designed to be cleaved by tumour-associated proteases, releasing cytotoxic drugs for the treatment and prevention of diseases, especially cancers.

Career Highlights:

Lisa Dietz has honed her expertise while working at prestigious companies such as Bayer Pharma Aktiengesellschaft and Bayer Aktiengesellschaft. Her innovative spirit and drive for excellence have led to significant advancements in the field of pharmaceuticals.

Collaborations:

Throughout her career, Lisa has collaborated with talented individuals such as Alexandros Vakalopoulos and Frank Wunder. Together, they have synergized their skills and knowledge to bring innovative solutions to life.

Conclusion:

In conclusion, Lisa Dietz's unwavering dedication to pushing the boundaries of technology and creating sustainable solutions cements her status as a pioneering inventor in the modern era. Her commitment to innovation and passion for making a positive impact on the world through her inventions truly sets her apart.

Profile summary based on public USPTO records.